A recent study unpicks a key immune-mediated mechanism of mutant IDH–blocking drugs such as vorasidenib in the treatment of IDH-mutant glioma.
The New England Journal of Medicine: Search Results in Neurology/Neurosurgery
Heating Up IDH-Mutant Gliomas
